Tamanho : 25mg
Synonyms:
| Description | Monoamine Oxidase B inhibitor 1 is a potent, reversible, orally active, and selective monoamine oxidase B (MAO-B) inhibitor (IC50 = 0.02 nM) capable of crossing the blood-brain barrier (BBB). It exhibits antioxidant and anti-neuroinflammatory activities and can be used in the study of Parkinson's disease[1]. |
| Targets & IC50 | MAO-B:0.02 nM, MAO-A:810 nM |
| In vitro | In cellular assays, the Monoamine Oxidase B inhibitor 1 (compound 14a; 0.5-10.0 μM) was shown to markedly reduce the levels of NO and TNF-α in LPS-induced BV-2 cells [1]. |
| In vivo | In both acute and subacute MPTP-induced Parkinson’s disease mouse models, Monoamine Oxidase B Inhibitor 1 (compound 14a; 6-37.4 mg/kg; orally administered) significantly ameliorated most behavioral disorders, restored dopamine levels and reduced MDA levels in the striatum of mice [1]. |
| Molecular Weight | 298.31 |
| Formula | C18H15FO3 |
| Smiles | #N/A |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO stock solution to 400 µL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|
